Downloads: 76
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| cia2.12166.pdf | 734.97 kB | Adobe PDF | View/Open |
| Title: | A possible case of maculopapular eruption associated with glecaprevir/pibrentasvir treatment for chronic hepatitis C virus infection |
| Authors: | Tomiyasu, Hiroka Nakajima, Saeko    https://orcid.org/0000-0003-0831-1447 (unconfirmed)Kaku, Yo Hirata, Masahiro Kataoka, Tatsuki Nomura, Takashi Kabashima, Kenji https://orcid.org/0000-0002-0773-0554 (unconfirmed) |
| Author's alias: | 冨安, 弘花 中島, 沙恵子 加来, 洋 平田, 勝啓 片岡, 竜貴 野村, 尚史 椛島, 健治 |
| Issue Date: | Aug-2021 |
| Publisher: | Wiley The Japanese Society for Cutaneous Immunology and Allergy |
| Journal title: | Journal of Cutaneous Immunology and Allergy |
| Volume: | 4 |
| Issue: | 4 |
| Start page: | 92 |
| End page: | 94 |
| Abstract: | Tomiyasu et al. report a possible case of maculopapular eruption associated with G/P treatment. Based upon the clinical course and histological analysis, the present case may be mediated by allergic mechanism. Since G/P treatment is widely used because of its efficacy and safety, clinical dermatologists should be aware that G/P may cause cutaneous drug eruption mediated by allergic responses. |
| Rights: | © 2021 The Authors. Journal of Cutaneous Immunology and Allergy published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society for Cutaneous Immunology and Allergy This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| URI: | http://hdl.handle.net/2433/277920 |
| DOI(Published Version): | 10.1002/cia2.12166 |
| Appears in Collections: | Journal Articles |
This item is licensed under a Creative Commons License
